Zynyz is close to EMA approval, but it won't be immediately available everywhere in Europe. Here's how to get the treatment at your own timeline.
Blog
-
March 05, 2024
-
March 05, 2024
Erdafitinib may get its EMA approval in 2024, but when will it be available on the market?
-
March 05, 2024
Can tazemetostat treat bladder cancer, prostate cancer, and more? Here's the latest research.
-
March 05, 2024
Tazverik seems a long way from EMA approval. If you can't wait, here are all your options to safely get the treatment.
-
February 21, 2024
Get the latest updates on Tofersen's EMA approval timeline and discover alternative ways to access the medicine in the meantime.
-
February 13, 2024
What does Relyvrio's recent EMA rejection mean for ALS patients in Europe? All you need to know (and what you can do to get the treatment quickly)
-
February 13, 2024
When will Radicut/Radicava(edaravone) be available to ALS patients in Europe and the UK (and what to do in the meantime).
-
February 06, 2024
When is the first nasal spray for dry eyes coming to Europe (and what to do in the meantime)
-
February 06, 2024
Topical roflumilast isn't likely to be available in Europe soon. Here's what you can expect, and some solutions for the meantime.
-
January 31, 2024
How effective is adagrasib for brain metastases? The latest data, and how to access the treatment quickly.
-
January 23, 2024
When are Elahere's EMA and MHRA approvals expected, and what can patients in Europe and the UK do in the meantime.
-
January 23, 2024
When will Leqembi receive MHRA approval? And how you can access the medicine in the meantime.
-
January 15, 2024
Ryzneuta's EMA and MHRA approvals seem nowhere in sight. Here's how you can access the medicine without waiting.
-
January 15, 2024
When will capivasertib be available to breast cancer patients in Europe and the UK? Approval status, timelines, and all your options for accessing the medicine quickly.
-
January 15, 2024
Everything you need to know about nitrogacestat's approval in Europe and the UK. Including all your options to access the medicine earlier.
-
January 08, 2024
What's after Enhertu? Some of the alternatives your doctor may consider if Enhertu starts working.
-
December 12, 2023
How does Herceptin compare to Enhertu? Find out the similarities and differences between these two treatments for HER2-positive cancer.
-
December 12, 2023
What is the age limit for ruxolitinib? Find out all about the potential use of Opzelura on children.
-
December 06, 2023
When is margetuximab's EMA and MHRA approval expected? And what are your options in the meantime?
-
December 06, 2023
Is reportrectinib getting EMA approval soon, and how can you access it in the meantime?
-
December 06, 2023
How effective is fruquintinib for lung cancer? The latest clinical trial results, and what they could mean for your treatment.
-
December 04, 2023
What is the fastest migraine relief medicine that you can get in Europe and the UK in 2023?
-
November 21, 2023
When can colorectal cancer patients in Europe and the UK expect to have access to Fruzaqla?
-
November 20, 2023
When will Ojjaara be available to myelofibrosis patients in Europe and the UK? And what you can do in the meantime.
-
November 13, 2023
What patients in Europe and the UK need to know about vamorolone's availability timeline.
-
November 13, 2023
When will Zavegepant be available in the UK (and what to do in the meantime)
-
November 06, 2023
Where is Enhertu approved for the treatment of advanced NSCLC, and how can you access it?
-
October 30, 2023
How to safely access Ozempic in Australia until the medicine shortage is resolved.
-
October 30, 2023
How to safely access Ozempic in the UK until the medicine shortage is resolved.
-
October 30, 2023
How effective is Enhertu for colorectal cancer? Find out the latest trial results and what they can mean for your treatment.